1. Protein arginine (N)-methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins.
- Author
-
Verbiest V, Montaudon D, Tautu MT, Moukarzel J, Portail JP, Markovits J, Robert J, Ichas F, and Pourquier P
- Subjects
- Animals, Cell Line, Tumor, Cricetinae, Down-Regulation, HeLa Cells, Humans, Isoenzymes genetics, Isoenzymes metabolism, Methyltransferases metabolism, Oligonucleotides, Antisense genetics, Protein-Arginine N-Methyltransferases, Antineoplastic Agents pharmacology, Camptothecin pharmacology, Drug Resistance, Neoplasm genetics, Methyltransferases genetics, Neoplasms enzymology
- Abstract
PRMT7 belongs to the protein arginine methyl-transferases family. We show that downregulation of PRMT7alpha and beta isoforms in DC-3F hamster cells was associated with increased sensitivity to the Top1 inhibitor camptothecin (CPT). This effect was not due to a change in Top1 contents or catalytic activity, or to a difference in the reversal of DNA breaks. Overexpression of PRMT7alpha and beta in DC-3F cells had no effect on CPT sensitivity, whereas it conferred a resistance to DC-3F/9-OH-E cells for which both isoforms are reduced by two- to three-fold as compared to DC-3F parental cells. Finally, downregulation of the human PRMT7 could also sensitize HeLa cells to CPT, suggesting that it could be used as a target to potentiate CPT derivatives.
- Published
- 2008
- Full Text
- View/download PDF